Company news: Pfizer, Incyte and Novartis
Pfizer's bid to expand the label of its Prevnar 13 pneumococcal vaccine garnered a near unanimous recommendation from FDA advisors.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.